SCHEMBL27609010

SCHEMBL27609010

CC1CCN(CCN2c3ccccc3SC2C=O)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 4/20 0.51
▸ SIGMAR1 Q99720 6/20 0.46
▸ ACHE P22303 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ CHRM2 P08172 1/20 0.42
▸ CHRM4 P08173 1/20 0.42
▸ CHRM5 P08912 1/20 0.42
▸ CHRM1 P11229 1/20 0.42
▸ DRD2 P14416 1/20 0.42
▸ CHRM3 P20309 1/20 0.42
▸ DRD4 P21917 1/20 0.42
▸ DRD3 P35462 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27590526 0.93 KDM1A (0.55) KDM1ASIGMAR1ACHEMEN1KMT2A
SCHEMBL27590543 0.83 CHRM1 (0.48) KDM1AMEN1KMT2ACHRM2CHRM4
SCHEMBL27609034 0.78 CHRM1 (0.50) KDM1AMEN1KMT2ACHRM2CHRM4
SCHEMBL27590503 0.77 CHRM1 (0.49) KDM1AMEN1KMT2ACHRM2CHRM4
SCHEMBL27590542 0.75 MEN1 (0.40) MEN1KMT2ACHRM2DRD2DRD3
SCHEMBL27609087 0.75 GSK3B (0.34) MEN1KMT2ASMN1; SMN2TP53
SCHEMBL27609192 0.74 ACHE (0.43) KDM1ASIGMAR1ACHECHRM2CHRM4
SCHEMBL28250648 0.74 ALDH1A1 (0.38) MEN1KMT2ASMN1; SMN2
SCHEMBL27609019 0.71 PIM1 (0.33) —
SCHEMBL27516784 0.69 MAOA (0.41) SMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1561212-A Benzimidazolone Derivatives as Muscarinic Agents ACADIA PHARM INC (US) 2005-01-05 — — CN disclosed
Send feedback